Selexipag — ingredient monograph

Overview

Source: NDC Directory

Ingredient name

SELEXIPAG

Base moiety

SELEXIPAG

RxNorm CUI

1729007

UNII

5EXC0E384L

Medication products

10

Brand names

2

Dosage forms

5

FAERS reports

25,685 · not a risk measure

Products containing this ingredient

Source: NDC Directory 10 products

Selexipag Powder
5 NDC
Selexipag Capsule
Rx 3 NDC
Selexipag (Form-I) Powder
1 NDC
Selexipag Amorphous Powder
1 NDC
SELEXIPAG-MANNITOL PREMIX Selexipag-Mannitol Premix · Powder
1 NDC
UPTRAVI Uptravi · Capsule
Rx 6 NDC
UPTRAVI Selexipag · Injection, Powder, for Solution
Rx NDA 1 NDC
Selexipag Tablet, Film Coated
Rx ANDA TE AB 16 NDC
UPTRAVI Selexipag · Tablet, Coated
Rx NDA TE AB 8 NDC
UPTRAVI Selexipag · Tablet, Film Coated
Rx NDA TE AB 2 NDC

Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.

By dosage form

How this ingredient is presented across the catalogue.
Dosage form	Products	Examples
Powder	4	Selexipag, Selexipag (Form-I), Selexipag Amorphous, SELEXIPAG-MANNITOL PREMIX
Capsule	2	Selexipag, UPTRAVI
TABLET, Film Coated	2	Selexipag, UPTRAVI
INJECTION, POWDER, For Solution	1	UPTRAVI
TABLET, Coated	1	UPTRAVI

Sources for this page

Dataset	Agency	Used for
NDC Directory	FDA	Ingredient name, strengths, products, labelers, packages
DailyMed RxNorm mappings	NLM	RxNorm concept identifier (RxCUI)
FAERS	FDA	Adverse event report totals